PACIFIC BIOSCIENCES DIRECTOR SPENDS $590M ON 500K Shares, Backs Undervalued Stock Amid Volatile Turnaround Plans
Pacific Biosciences insider trades reveal a strategic buy‑sell pattern: Gibson James R II’s 500k share purchase at $1.18 signals confidence in PACB’s SMRT sequencing future.
- PACIFIC BIOSCIENCES of CALIF
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
3 minutes to read